Impact of EXO1 (K589E) Genetic Variant on Breast Cancer Risk: Evidence From Bangladesh
Open Access
- 23 September 2026
- journal article
- Published by SAGE Publications in Breast Cancer: Basic and Clinical Research
- Vol. 20
Abstract
Background: Exonuclease 1 ( EXO1 ) is a key nuclease in the DNA mismatch repair (MMR) pathway and is involved in correcting replication errors while maintaining genomic stability. The K589E (rs1047840) single nucleotide polymorphism (SNP) of EXO1 has been associated with cancer susceptibility in different populations. Objectives: This study aimed to investigate the association between the EXO1 K589E polymorphism and breast cancer risk, as well as its relationship with selected clinicopathological characteristics in Bangladeshi women. Design: Hospital-based case-control study. Methods: The present case–control study included 184 patients with histologically confirmed breast cancer and 200 age-matched cancer-free controls. Genotyping of the EXO1 K589E variant was carried out using polymerase chain reaction–restriction fragment length polymorphism (PCR-RFLP) analysis and subsequently confirmed by direct sequencing. The associations between the polymorphism and breast cancer risk were assessed using logistic regression, with odds ratios (ORs) and corresponding 95% confidence intervals (CIs) calculated. Results: The frequencies of G/G, G/A, and A/A genotypes were 49.5, 41.8, and 8.7% among cases, compared with 69, 27.5, and 3.5% among controls, respectively. Both the heterozygous (G/A) and homozygous variant (A/A) genotypes were significantly associated with elevated breast cancer risk (OR= 2.12, 95% CI= 1.37-3.28, p = 0.0007; OR= 3.46, 95 % CI= 1.37-8.76, p = 0.0086, respectively). The combined variant genotypes (G/A + A/A) conferred a 2.27-fold higher risk ( p = 0.0001), and the A allele was also strongly associated with breast cancer predisposition (OR= 2.01, 95% CI= 1.43-2.84, p = 0.0001). The association remained significant under codominant, dominant, recessive, overdominant, and log-additive genetic models. Significant correlations were observed between the variant genotype and menopausal status, body mass index (BMI), and tumor stage. Conclusion: The results indicate that the EXO1 K589E polymorphism is significantly associated with an increased risk of breast cancer in Bangladeshi women and may also be related to key clinicopathological features of the disease.Keywords
This publication has 59 references indexed in Scilit:
- Molecular pathology in breast disease: diagnostic, prognostic, and therapeutic toolsVirchows Archiv, 2023
- DNA mismatch repair deficient cancer – Emerging biomarkers of resistance to immune checkpoint inhibitionThe International Journal of Biochemistry & Cell Biology, 2023
- Breast Cancer and Lifestyle FactorsHematology/Oncology Clinics of North America, 2023
- The nuclease activity of DNA2 promotes exonuclease 1–independent mismatch repairJournal of Biological Chemistry, 2022
- Genetic polymorphisms in DNA repair genes and hepatocellular carcinoma riskDNA Repair, 2021
- Epidemiology of breast cancer among the female patients in BangladeshAdvances in Traditional Medicine, 2016
- World Medical Association Declaration of HelsinkiJAMA, 2013
- The significance of Exonuclease 1 K589E polymorphism on hepatocellular carcinoma susceptibility in the Turkish population: a case–control studyMolecular Biology Reports, 2011
- EXO1-A multi-tasking eukaryotic nucleaseDNA Repair, 2004
- Mismatch repair and DNA damage signallingDNA Repair, 2004